Nevertheless, no statistically significant correlations were observed between MAPK12 expression and gender, age, number of extranodal invasions, tumor size, ECOG score, B symptoms, Ann Arbor stage, or therapy. The gene discussed is MAPK12; the disease is neoplasm.